Searched for
BIONTECH PFIZER
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...- GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...
- German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patentA German court has ruled that Pfizer and BioNTech violated Moderna's COVID-19 vaccine patent. The court in Duesseldorf stated that Pfizer a...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
- EU plans to boost reach of Pfizer COVID-19 shotThe European Medicines Agency said it would review data, including results from an ongoing study, for the vaccine - known as Comirnaty. It ...
- No need yet to adapt Pfizer vaccine for coronavirus variants, says BioNTech chiefA decision to make a switch should be made only if it is clear that the vaccine failed to work or is only offering sub-par protection again...
- BioNTech committed to deliver 1.8 billion doses of COVID-19 vaccine this yearBioNTech's first-quarter total revenues were 2.05 billion euros, up from 27.7 million a year earlier, inflated by the vaccine, and includin...
- Pfizer to pursue bringing COVID-19 vaccine to India after import relaxation"We remain committed to continuing our engagement with the government towards making the Pfizer and BioNTech vaccine available for use in t...
- BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 billion dosesPfizer previously said the partners would likely produce between 2.3 billion and 2.4 billion doses in 2021. BioNTech cited its new facility...
- Hong Kong halts Pfizer/BioNTech COVID-19 vaccines, investigates defective packagingThe government said it had received notice from Fosun Pharma Industrial (Hong Kong), the distributor of the Pfizer/BioNTech vaccine in the ...
- Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infectionThe companies also said the latest analysis of the Israeli data shows the vaccine was 97% effective in preventing symptomatic disease, seve...
- Pfizer-BioNTech say Covid vaccine works against UK, South Africa variantsWhile the findings indicated no need for a new vaccine to tackle the new strains, Pfizer and BioNTech said they would respond if there was ...
- BioNTech founders warn of vaccine supply gapsThe delays in rolling out the home-grown vaccine have caused consternation in Germany, where some regions had to halt vaccinations within d...
- Dubai to begin inoculations with Pfizer-BioNTech vaccine from WednesdayDubai will start inoculating people with the COVID-19 vaccine produced by Pfizer and BioNTech for free from Wednesday, the emirate's govern...
- BioNTech, Pfizer ask Europe to quickly approve virus vaccineThe German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for speeded-up, conditional a...
- Pfizer shares surge nearly 4% on vaccine reportGlobal drugmakers Pfizer and BioNTech said on Wednesday that their COVID-19 vaccine was found 95 per cent effective in the final analysis o...
- U.S. to pay Pfizer and BioNTech $1.95 billion to produce millions of doses of COVID-19 vaccinePfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, ...
- Pfizer, BioNTech to co-develop potential coronavirus vaccineThe drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine's distribution outside China, th...
Load More
